Sofosbuvir–velpatasvir plus ribavirin in Japanese patients with genotype 1 or 2 hepatitis C who failed direct-acting antivirals
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1936-0541
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Sofosbuvir–velpatasvir plus ribavirin in Japanese patients with genotype 1 or 2 hepatitis C who failed direct-acting antivirals ; volume:12 ; number:4 ; day:20 ; month:7 ; year:2018 ; pages:356-367 ; date:7.2018
Hepatology international ; 12, Heft 4 (20.7.2018), 356-367, 7.2018
- Creator
-
Izumi, Namiki
- Contributor
-
Takehara, Tetsuo
Chayama, Kazuaki
Yatsuhashi, Hiroshi
Takaguchi, Koichi
Ide, Tatsuya
Kurosaki, Masayuki
Ueno, Yoshiyuki
Toyoda, Hidenori
Kakizaki, Satoru
Tanaka, Yasuhito
Kawakami, Yoshiiku
Enomoto, Hirayuki
Ikeda, Fusao
Jiang, Deyuan
De-Oertel, Shampa
McNabb, Brian L.
Camus, Gregory
Stamm, Luisa M.
Brainard, Diana M.
McHutchison, John G.
Mochida, Satoshi
Mizokami, Masashi
SpringerLink (Online service)
- DOI
-
10.1007/s12072-018-9878-6
- URN
-
urn:nbn:de:101:1-2018100519295085954330
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:35 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Izumi, Namiki
- Takehara, Tetsuo
- Chayama, Kazuaki
- Yatsuhashi, Hiroshi
- Takaguchi, Koichi
- Ide, Tatsuya
- Kurosaki, Masayuki
- Ueno, Yoshiyuki
- Toyoda, Hidenori
- Kakizaki, Satoru
- Tanaka, Yasuhito
- Kawakami, Yoshiiku
- Enomoto, Hirayuki
- Ikeda, Fusao
- Jiang, Deyuan
- De-Oertel, Shampa
- McNabb, Brian L.
- Camus, Gregory
- Stamm, Luisa M.
- Brainard, Diana M.
- McHutchison, John G.
- Mochida, Satoshi
- Mizokami, Masashi
- SpringerLink (Online service)
Other Objects (12)
A systematic review of sofosbuvir/velpatasvir/voxilaprevir in HCV patients previously treated with direct-acting antivirals
Direct-acting antivirals and visceral leishmaniasis: a case report
Drug–Drug Interactions Between Direct-Acting Antivirals and Psychoactive Medications
Dynamic evolution of the sofosbuvir-associated variant A1343V in HEV-infected patients under concomitant sofosbuvir-ribavirin treatment
Economic Evaluation of Direct-Acting Antivirals for Hepatitis C in Norway
Estimating the cost-effectiveness of daclatasvir + sofosbuvir versus sofosbuvir + ribavirin for patients with genotype 3 hepatitis C virus
Serum autotaxin levels in responders to HCV treatment by direct-acting antivirals
Hepatitis C clearance by direct-acting antivirals impacts glucose and lipid homeostasis
Long term changes in thrombocytopenia and leucopenia after HCV eradication with direct-acting antivirals
Impact of direct-acting antivirals on neuropsychiatric and neurocognitive dysfunction in chronic hepatitis C patients
Secular trends in cryoglobulinemia mortality in the USA in the era of direct-acting antivirals
Impact of HCV eradication following direct-acting antivirals on liver stiffness measurement: a prospective longitudinal study
A systematic review of sofosbuvir/velpatasvir/voxilaprevir in HCV patients previously treated with direct-acting antivirals
Direct-acting antivirals and visceral leishmaniasis: a case report
Drug–Drug Interactions Between Direct-Acting Antivirals and Psychoactive Medications
Dynamic evolution of the sofosbuvir-associated variant A1343V in HEV-infected patients under concomitant sofosbuvir-ribavirin treatment
Economic Evaluation of Direct-Acting Antivirals for Hepatitis C in Norway
Estimating the cost-effectiveness of daclatasvir + sofosbuvir versus sofosbuvir + ribavirin for patients with genotype 3 hepatitis C virus
Serum autotaxin levels in responders to HCV treatment by direct-acting antivirals
Hepatitis C clearance by direct-acting antivirals impacts glucose and lipid homeostasis
Long term changes in thrombocytopenia and leucopenia after HCV eradication with direct-acting antivirals
Impact of direct-acting antivirals on neuropsychiatric and neurocognitive dysfunction in chronic hepatitis C patients
Secular trends in cryoglobulinemia mortality in the USA in the era of direct-acting antivirals
Impact of HCV eradication following direct-acting antivirals on liver stiffness measurement: a prospective longitudinal study
A systematic review of sofosbuvir/velpatasvir/voxilaprevir in HCV patients previously treated with direct-acting antivirals
Direct-acting antivirals and visceral leishmaniasis: a case report
Drug–Drug Interactions Between Direct-Acting Antivirals and Psychoactive Medications
Dynamic evolution of the sofosbuvir-associated variant A1343V in HEV-infected patients under concomitant sofosbuvir-ribavirin treatment
Economic Evaluation of Direct-Acting Antivirals for Hepatitis C in Norway
Estimating the cost-effectiveness of daclatasvir + sofosbuvir versus sofosbuvir + ribavirin for patients with genotype 3 hepatitis C virus
Serum autotaxin levels in responders to HCV treatment by direct-acting antivirals
Hepatitis C clearance by direct-acting antivirals impacts glucose and lipid homeostasis
Long term changes in thrombocytopenia and leucopenia after HCV eradication with direct-acting antivirals
Impact of direct-acting antivirals on neuropsychiatric and neurocognitive dysfunction in chronic hepatitis C patients
Secular trends in cryoglobulinemia mortality in the USA in the era of direct-acting antivirals